Comparing Universal Lynch Syndrome Tumor-Screening Programs
This dataset is from Cragun et al. (2014), who analyze the association between different universal tumor screening procedures and certain levels of patient follow-through with germ-line testing for Lynch Syndrome after a screen-positive result using csQCA.
data(d.tumorscreen)
This data frame contains 15 rows (cases) and the following 8 columns (factors):
[ , 1] | HPF | endogenous factor | : | high patient follow-through | ("1" yes, "0" no) |
[ , 2] | LPF | endogenous factor | : | low patient follow-through | ("1" yes, "0" no) |
[ , 3] | CA | exogenous factor | : | challenges to adoption at least as high as facilitators | ("1" yes, "0" no) |
[ , 4] | AR | exogenous factor | : | automatic reflex test of screen-positive tumors | ("1" yes, "0" no) |
[ , 5] | RR | exogenous factor | : | genetic counselor receives positive screen results | ("1" yes, "0" no) |
[ , 6] | DR | exogenous factor | : | genetic counselor discloses screening result to patient | ("1" yes, "0" no) |
[ , 7] | DC | exogenous factor | : | difficulty in contacting patients | ("1" yes, "0" no) |
[ , 8] | PR | exogenous factor | : | need for physician referral is a barrier | ("1" yes, "0" no) |
Thiem, Alrik: collection, documentation |
Alrik Thiem (Personal Website; ResearchGate Website)
Cragun, Deborah, Rita D. DeBate, Susan T. Vadaparampil, Julie Baldwin, Heather Hampel, and Tuya Pal. 2014. “Comparing Universal Lynch Syndrome Tumor-Screening Programs to Evaluate Associations between Implementation Strategies and Patient Follow-Through.” Genetics in Medicine 16 (10):773-82. DOI: 10.1038/gim.2014.31.
Please choose more modern alternatives, such as Google Chrome or Mozilla Firefox.